Received 09/23/2022 review began 10/27/2022 review ended 02/16/2023 published 02/16/2023

HIGHLIGHTS

• who: Devanjali D. Pajai et al. from the (UNIVERSITY) have published the research: Received 09/23/2022 Review began 10/27/2022 Review ended 02/16/2023 Published 02/16/2023, in the Journal: (JOURNAL) of February/16,/2023
• what: The aims of this review are as follows: Pharmacotherapy for tobacco cessation. The aim of treatment for alcohol and opioid use disorders is to change the factors that reinforce euphoric induction.
• future: It is recommended that it should be used for at least 8 to 12 weeks before progressively reducing the number of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.